Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report)’s stock price was down 4.8% on Friday . The stock traded as low as $14.52 and last traded at $14.70. Approximately 23,268 shares changed hands during trading, a decline of 96% from the average daily volume of 561,417 shares. The stock had previously closed at $15.44. Analyst […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Shares Gap Up to $12.82 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.